Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

AutoImmune will conduct pivotal study of Colloral

Feb. 27, 1998

Beneficial effects of FK-506 in animal model of rheumatoid arthritis

Feb. 27, 1998

Orthovisc PMA accepted for filing by FDA

Feb. 25, 1998

Selective inhibitor of p38 MAP kinase effective in chronic inflammatory diseases

Feb. 25, 1998

Flobufen update

Feb. 24, 1998

First phase II results reported for EuroAlliance's DAAID

Feb. 23, 1998

Patent coverage for Idec's humanized antibody for SLE

Feb. 23, 1998

Pfizer will copromote Searle's COX-2 inhibitors in U.S.

Feb. 20, 1998

FDA approves new indication for pilocarpine

Feb. 19, 1998

Small-molecule chemokine receptor antagonists from Teijin

Feb. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...